So, Ivosidenib is like a new kind of medicine that’s a big help for patients with AML and a specific IDH1 mutation, especially when their disease comes back or doesn’t respond to treatment. It goes after the faulty IDH1 and stops cancer cells from growing. You can get it as tablets, kind of like a coated pill, and each one’s 250 milligrams.
The usual dosage is 500 milligrams, taken just once a day, orally. Each bottle holds about 60 tablets. The thing is, the way it’s made is designed to keep most of it just targeting cancer cells, so it doesn’t mess up your normal blood cells, while still being really good at doing its job.
They check for IDH1 mutations before you start using Ivosidenib to make sure it’s the best choice for you. It stays in your system for a bit, like 5.4 hours after you take a dose, and then you just need to take 500 mg every day without constant blood tests. If it seems like the medicine isn’t doing its job anymore, you might need some extra help.
Ivosidenib’s been cleared by the FDA, and it works by keeping bad stuff, like 2-hydroxyglutarate, under control, mainly because it depends on how much of it you have in your body. Patients with different illnesses shouldn’t start Ivosidenib unless they’re sure it’s right for them, and some other tests confirm it’s safe.
Reviews
There are no reviews yet.